Table 3.
Pregnancy outcomes related to the percentage of blastomere loss following single frozen-thawed embryo transfer
| Percentage of blastomere loss | p 1 a | p 2 a | p 3 a | p for trend b | |||
|---|---|---|---|---|---|---|---|
| 0% (n = 803) | ≤ 25% (n = 154) | 26–50% (n = 166) | |||||
| Chemical pregnancies (n, %)c | 169(21.1) | 35 (22.7) | 18 (10.8) | 0.641 | 0.002 | 0.004 | 0.018 |
| Clinical pregnancies (n, %)d | 145 (18.1) | 28 (18.2) | 15 (9.0) | 0.971 | 0.004 | 0.017 | 0.020 |
| Ongoing pregnancies (n, %)e | 120 (14.9) | 26 (16.9) | 12 (7.2) | 0.540 | 0.008 | 0.008 | 0.021 |
| Live births (n, % per embryo transfer cycle)f | 114 (14.2) | 25 (16.2) | 10 (6.0) | 0.511 | 0.004 | 0.004 | 0.041 |
| Live births (n, % per clinical pregnancy)g | 114 (77.1) | 25 (89.3) | 10 (66.7) | 0.194 | 0.331 | 0.104 | 0.950 |
| Ectopic pregnancies (n, %) | 4 (0.5) | 0 (0.0) | 0 (0.0) | 0.380 | 1.000 | NA | 0.219 |
| Early miscarriages (n, % per clinical pregnancy) | 25 (17.2) | 2 (7.7) | 3 (17.7) | 0.257 | 0.728 | 0.324 | 0.503 |
| Pregnancy termination due to fetal anomaly (n, % per clinical pregnancy) h | 1 (0.7) | 0 (0.0) | 0 (0.0) | 1.000 | 1.000 | NA | 0.531 |
NA not accessible
aP values were calculated using Pearson χ2 test or Fisher exact test, p1 for comparisons between 0% and ≤ 25% group, p2 for comparisons between 0% and 26–50% group, p3 for comparisons between ≤ 25% and 26–50% group
bPfor trend was calculated using Cochran–Mantel–Haenszel test, and adjusted for primary infertility and the type of FET cycle
cChemical pregnancy was defined as an elevated serum β-hCG level of more than 10 mIU/mL. Chemical pregnancy rate was defined as the number of chemical pregnancies divided by the number of embryo transfer cycle for each group
dClinical pregnancy was defined as a pregnancy documented by ultrasound at 6–8 gestational weeks that showed a gestational sac in the uterus. Clinical pregnancy rate was defined as the number of clinical pregnancies divided by the number of embryo transfer cycles for each group
eOngoing pregnancy was defined as a pregnancy documented by ultrasound at 12 gestational weeks that showed the presence of fetal heartbeat. Ongoing pregnancy rate was defined as the number of ongoing pregnancies divided by the number of embryo transfer cycles for each group
fLive birth was defined as the delivery of one or more infants with any signs of life after 28 gestational weeks. Live birth rate (% per embryo transfer cycle) was defined as the number of live births divided by the number of embryo transfer cycles for each group
gLive birth rate (% per clinical pregnancy) was defined as the number of live births divided by the number of clinical pregnancies for each group
hOne patient in 0% group terminated the pregnancy due to achondroplasia